236 results on '"Gribben, John G"'
Search Results
2. MD-1 downregulation is associated with reduced cell surface CD180 expression in CLL
3. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
4. NK cells CD56bright and CD56dim subset cytokine loss and exhaustion is associated with impaired survival in myeloma
5. Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
6. Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways
7. Retinoic acid–responsive CD8 effector T cells are selectively increased in IL-23–rich tissue in gastrointestinal GVHD
8. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice
9. How and when I do allogeneic transplant in CLL
10. High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
11. TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses
12. Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
13. Mechanisms of PD-L1/PD-1–mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Eµ-TCL1 CLL mouse model
14. PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia
15. Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo
16. Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia
17. Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia
18. Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants
19. Genomic profiling for clinical decision making in lymphoid neoplasms
20. Deep Multi-Omics Profiling in Cytogenetically Poor-Risk AML
21. Five-Year Results and Overall Survival Update from the Phase 3 Randomized Study Augment: Lenalidomide Plus Rituximab (R2) Vs Rituximab Plus Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
22. Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells
23. The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies
24. Chronic lymphocytic leukemia cells induce defective LFA-1–directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide
25. T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
26. The role of B7 family molecules in hematologic malignancy
27. Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
28. Risk categories and refractory CLL in the era of chemoimmunotherapy
29. A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia
30. Stem Cell Transplantation for Indolent Lymphoma and Chronic Lymphocytic Leukemia
31. GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
32. CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia
33. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction
34. How I treat CLL up front
35. Stem cell transplantation in chronic lymphocytic leukaemia – steering a safe course over shifting sands
36. Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy
37. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts
38. Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia
39. Comparative Effectiveness of Axicabtagene Ciloleucel Vs Historical Standard-of-Care in Patients with Relapsed or Refractory Follicular Lymphoma: An Analysis of CIBMTR and SCHOLAR-5 Data
40. Allele-Specific Expression of Leukemia Genes Is Associated with Pathogenicity in Poor Risk AML
41. Cryopreserved Versus Non-Cryopreserved Peripheral Blood Haematopoietic Stem Cells for Autologous Stem Cell Transplantation in Multiple Myeloma: A Comparative Analysis from the Chronic Malignancies Working Party of EBMT and WBMT
42. Ibrutinib Plus Venetoclax with MRD-Directed Duration of Treatment Is Superior to FCR and Is a New Standard of Care for Previously Untreated CLL: Report of the Phase III UK NCRI FLAIR Study
43. Physician Treatment Preferences in Relapsed/Refractory Follicular Lymphoma: A Discrete Choice Experiment
44. The Value of Collaboration with Patient Advocacy Organizations to Enhance Initiatives Focused on Patient-Centered Care and Improve Outcomes in Chronic Lymphocytic Leukemia
45. A Novel Approach: Nanopore Sequencing of Native Cell-Free DNA in Diffuse-Large B-Cell Lymphoma Patients
46. An Updated Comparison of Clinical Outcomes from 4-Year Follow-up of Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma
47. The XPO1-FOXC1-HOX Functional Axis Opens New Therapeutic Avenues to Treat DEK-NUP214 AML Patients
48. Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib
49. Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies
50. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.